Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprocitentan in resistant hypertension
CTR20182356Phase 3Active
- Sponsor
- Tigermed
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aprocitentan in resistant hypertension (RH), sponsored by Tigermed. Started Apr 2019; status: active.
02
Drugs
aprocitentan
03
Conditions
resistant hypertension (RH)
Beyond the preview
Go deeper on CTR20182356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20182356.